Announcements Trials
Browse Landscape

Phase

Phase NA 59Phase 2 4Phase 2/3 2Phase EARLY_PHASE1 1Phase 3 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Breast 2Other 1Head & Neck 1Genitourinary 1

Conditions

Colonic Neoplasms 1Colon Cancer Prevention 1

Interventions

Oxaliplatin 49Fluorouracil 46Capecitabine 41Cisplatin 36Gemcitabine 29Leucovorin 27Bevacizumab 21Drug Therapy 20Paclitaxel 15Folfox protocol 15Radiotherapy 14Irinotecan 14apatinib 11Neoadjuvant Therapy 11Docetaxel 11sintilimab 9S 1 (combination) 9Sorafenib 8Nivolumab 8Trastuzumab 7Surgical Procedures, Operative 7Magnetic Resonance Spectroscopy 7lenvatinib 6atezolizumab 6XELOX 6Cetuximab 6Albumin-Bound Paclitaxel 6130-nm albumin-bound paclitaxel 6tislelizumab 5pembrolizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Exercise × Gastrointestinal × Clear all
NCT00813540 2016-03-11

The Effects of Exercise Training on the Health-related Fitness of Colon Cancer Survivors

AHS Cancer Control Alberta

Phase 2/3 Completed
52 enrolled
Gastrointestinal

Colonic Neoplasms

NCT00668161 2012-11-28

APPEAL

Fred Hutchinson Cancer Center

Phase 2/3 Completed
202 enrolled
Gastrointestinal

Colon Cancer Prevention

Data powered by HemOnc (CC BY 4.0) Colophon âš¡